Look at PDLI for a company with an overarching patent on biological drugs...has not done much for the company per se...worth something yes, but it was their drug development program that was the big value driver, not the royalties.
In drugs, bring to market drugs. Far more profitable the protected drug market vs. a royalty or licensing fee.
Market Data 
Markets 
AI
